1 – 10 of 21
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2024
-
Mark
Loss of Chromosome Y in Neuroblastoma Is Associated With High-Risk Disease, 11q-Deletion, and Telomere Maintenance
(
- Contribution to journal › Article
-
Mark
Diagnostic yield and clinical impact of germline sequencing in children with CNS and extracranial solid tumors—a nationwide, prospective Swedish study
(
- Contribution to journal › Article
- 2023
-
Mark
The Swedish childhood tumor biobank : systematic collection and molecular characterization of all pediatric CNS and other solid tumors in Sweden
(
- Contribution to journal › Article
-
Mark
Diagnostic Yield From a Nationwide Implementation of Precision Medicine for all Children With Cancer
(
- Contribution to journal › Article
- 2022
-
Mark
The immune cell atlas of human neuroblastoma
(
- Contribution to journal › Article
-
Mark
A Phase II Trial of a Personalized, Dose-Intense Administration Schedule of 177Lutetium-DOTATATE in Children With Primary Refractory or Relapsed High-Risk Neuroblastoma–LuDO-N
(
- Contribution to journal › Article
-
Mark
Sustained Response to Entrectinib in an Infant With a Germline ALKAL2 Variant and Refractory Metastatic Neuroblastoma With Chromosomal 2p Gain and Anaplastic Lymphoma Kinase and Tropomyosin Receptor Kinase Activation
(
- Contribution to journal › Article
-
Mark
Amplification of CDK4 and MDM2 : a detailed study of a high-risk neuroblastoma subgroup
(
- Contribution to journal › Article
- 2020
-
Mark
Integrative discovery of treatments for high-risk neuroblastoma
(
- Contribution to journal › Article
-
Mark
11q Deletion or ALK Activity Curbs DLG2 Expression to Maintain an Undifferentiated State in Neuroblastoma
(
- Contribution to journal › Article